Provided by Tiger Fintech (Singapore) Pte. Ltd.

CH BIOTECH SER

1.070
+0.0504.90%
Volume:3.07M
Turnover:3.42M
Market Cap:1.04B
PE:-5.23
High:1.210
Open:1.090
Low:1.060
Close:1.020
52wk High:1.330
52wk Low:0.250
Shares:975.73M
HK Float Shares:975.73M
Volume Ratio:5.06
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.205
ROE:-54.91%
ROA:-9.54%
PB:4.37
PE(LYR):-5.23
PS:13.57

Loading ...

Company Profile

Company Name:
CH BIOTECH SER
Exchange:
SEHK
Establishment Date:
1996
Employees:
133
Office Location:
Suites 1904-05A,19 Floor, Sino Plaza,255-257 Gloucester Road,Causeway Bay,Hong Kong
Zip Code:
- -
Fax:
852 2151 3968
Introduction:
China Biotech Services Holdings Ltd, formerly Rui Kang Pharmaceutical Group Investments Ltd, is an investment holding company principally engaged in the provision of medical health check services. The Company operates its business through six segments. The Medical and Health Related Services segment provides medical laboratory testing services and health check services. The Insurance Brokerage segment is engaged in the provision of brokerage services. The Immunotherapy segment provides tumor immune call therapy, immune cell storage and health management services. The Pharmaceutical Products segment is engaged in the manufacture, research and development, sale and distribution of health related and pharmaceutical products. The Securities segment is engaged in the trading of securities. The Others segment is engaged in the money lending business and provision of logistic services.

Directors

Name
Position
LIU Xiao Lin
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
HE Xun
Executive Director
HUANG Song
Executive Director
YIN Ye
Executive Director
YAN Guo Xiang
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Chairman
GUO Yuan Tao
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
ZHANG Xiao
Independent Director,Audit Committee Member

Shareholders

Name
Position
FENG Pei Xian
CFO,Corporate Secretary
LIU Xiao Lin
Compliance Director